0
views
0
recommends
+1 Recommend
1 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found

      Action of Prolactin, Dopamine and LHRH on Ventromedial Hypothalamic Neurons as a Function of Ovarian Hormones

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          The effect of iontophoretically-applied prolactin, dopamine, LHRH and LHRH-antagonist analog on the electrical activity of neurons (n = 192) located in the ventromedial nucleus of the hypothalamus (VMH) was studied in untreated and hormone-treated ovariectomized female rats (n = 63). The spontaneous electrical activity of VMH neurons was unaffected by the presence or absence of the ovarian hormones. Neuropharmacological studies indicate that the iontophoretic deposition of prolactin and dopamine produced opposing results, in that prolactin increased the electrical activity of the majority of the VMH neurons tested while dopamine decreased their activity. Finally, the application of LHRH and LHRH-antagonist analog to VMH neurons resulted in a marked suppression of their electrical activity that was even more pronounced in the presence of ovarian hormones. The present work provides evidence at the electrophysiological level of hormonal influences on the responsiveness of VMH neurons to LHRH and its antagonist analog, and demonstrates a relationship between the responsiveness of VMH neurons to prolactin and dopamine.

          Related collections

          Author and article information

          Journal
          NEN
          Neuroendocrinology
          10.1159/issn.0028-3835
          Neuroendocrinology
          S. Karger AG
          0028-3835
          1423-0194
          1983
          1983
          26 March 2008
          : 36
          : 5
          : 397-403
          Affiliations
          Department of Physiology, University of Texas Health Science Center at Dallas, Southwestern Medical School, Dallas, Tex., USA
          Article
          123487 Neuroendocrinology 1983;36:397–403
          10.1159/000123487
          6343908
          © 1983 S. Karger AG, Basel

          Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher. Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug. Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.

          Page count
          Pages: 7
          Categories
          Original Paper

          Comments

          Comment on this article